Stiff person syndrome and other anti-GAD-associated neurologic disorders

Seminars in Neurology

Volumn 32, Issue 5, 2012, Pages 544-549

  Dayalu, Praveen ^a   Teener, James W ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

cerebellar ataxia; GAD antibodies; limbic encephalitis; muscle stiffness; progressive encephalomyelitis with rigidity and myoclonus; stiff person syndrome

Indexed keywords

ALPRAZOLAM; BACLOFEN; CLONAZEPAM; DANTROLENE; DIAZEPAM; GABAPENTIN; GLUTAMATE DECARBOXYLASE ANTIBODY; LORAZEPAM; TIAGABINE; VALPROIC ACID; VIGABATRIN;

AGONIST MUSCLE; ANTAGONIST MUSCLE; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; CEREBELLAR ATAXIA; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DYSARTHRIA; ELECTRODIAGNOSIS; ELECTROMYOGRAPHY; EPILEPSY; FALLING; FEAR; GAIT DISORDER; GRAVES DISEASE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MUSCLE; MUSCLE RIGIDITY; MUSCLE SPASM; NONPARANEOPLASTIC LIMBIC ENCEPHALITIS; NYSTAGMUS; ONSET AGE; PARANEOPLASTIC NEUROPATHY; PATHOGENESIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SEX DIFFERENCE; STIFF MAN SYNDROME;

AUTOANTIBODIES; CENTRAL NERVOUS SYSTEM; FEMALE; GAMMA-AMINOBUTYRIC ACID; GLUTAMATE DECARBOXYLASE; HUMANS; MIDDLE AGED; MUSCLE RIGIDITY; SPASM; STIFF-PERSON SYNDROME;

EID: 84878061155     PISSN: 02718235     EISSN: 10989021     Source Type: Journal    
DOI: 10.1055/s-0033-1334477     Document Type: Article

References (41)

1. Honnorat J., Saiz A., Giometto B., et al. Cerebellar ataxia with anti-glutamic acid decarboxylase antibodies: study of 14 patients. Arch Neurol: 2001; 58 2 225 230
2. Saiz A., Arpa J., Sagasta A., et al. Autoantibodies to glutamic acid decarboxylase in three patients with cerebellar ataxia, late-onset insulin-dependent diabetes mellitus, and polyendocrine autoimmunity. Neurology: 1997; 49 4 1026 1030
3. Saiz A., Blanco Y., Sabater L., et al. Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association. Brain: 2008; 131 Pt 10 2553 2563
4. Kono S., Miyajima H., Sugimoto M., Suzuki Y., Takahashi Y., Hishida A. Stiff-person syndrome associated with cerebellar ataxia and high glutamic acid decarboxylase antibody titer. Intern Med: 2001; 40 9 968 971
5. Hadjivassiliou M., Boscolo S., Tongiorgi E., et al. Cerebellar ataxia as a possible organ-specific autoimmune disease. Mov Disord: 2008; 23 10 1370 1377
6. Whiteley A. M., Swash M., Urich H. Progressive encephalomyelitis with rigidity. Brain: 1976; 99 1 27 42
7. Pittock S. J., Yoshikawa H., Ahlskog J. E., et al. Glutamic acid decarboxylase autoimmunity with brainstem, extrapyramidal, and spinal cord dysfunction. Mayo Clin Proc: 2006; 81 9 1207 1214
8. Matà S., Muscas G. C., Naldi I., et al. Non-paraneoplastic limbic encephalitis associated with anti-glutamic acid decarboxylase antibodies. J Neuroimmunol: 2008; 199 1-2 155 159
9. Malter M. P., Helmstaedter C., Urbach H., Vincent A., Bien C. G. Antibodies to glutamic acid decarboxylase define a form of limbic encephalitis. Ann Neurol: 2010; 67 4 470 478
10. Graus F., Saiz A., Lai M., et al. Neuronal surface antigen antibodies in limbic encephalitis: clinical-immunologic associations. Neurology: 2008; 71 12 930 936
11. McKeon A., Robinson M. T., McEvoy K. M., et al. Stiff-man syndrome and variants: clinical course, treatments, and outcomes. Arch Neurol: 2012; 69 2 230 238
12. Liimatainen S., Peltola M., Sabater L., et al. Clinical significance of glutamic acid decarboxylase antibodies in patients with epilepsy. Epilepsia: 2010; 51 5 760 767
13. Yoshimoto T., Doi M., Fukai N., et al. Type 1 diabetes mellitus and drug-resistant epilepsy: presence of high titer of anti-glutamic acid decarboxylase autoantibodies in serum and cerebrospinal fluid. Intern Med: 2005; 44 11 1174 1177
14. Peltola J., Kulmala P., Isojärvi J., et al. Autoantibodies to glutamic acid decarboxylase in patients with therapy-resistant epilepsy. Neurology: 2000; 55 1 46 50
15. Verrotti A., Greco R., Altobelli E., Latini G., Morgese G., Chiarelli F. Anticardiolipin, glutamic acid decarboxylase, and antinuclear antibodies in epileptic patients. Clin Exp Med: 2003; 3 1 32 36
16. Kwan P., Brodie M. J. Early identification of refractory epilepsy. N Engl J Med: 2000; 342 5 314 319
17. Errichiello L., Perruolo G., Pascarella A., et al. Autoantibodies to glutamic acid decarboxylase (GAD) in focal and generalized epilepsy: a study on 233 patients. J Neuroimmunol: 2009; 211 1-2 120 123
18. Zivotofsky A. Z., Siman-Tov T., Gadoth N., Gordon C. R. A rare saccade velocity profile in stiff-person syndrome with cerebellar degeneration. Brain Res: 2006; 1093 1 135 140
19. Solimena M., Folli F., Aparisi R., Pozza G., De Camilli P. Autoantibodies to GABA-ergic neurons and pancreatic beta cells in stiff-man syndrome. N Engl J Med: 1990; 322 22 1555 1560
20. Butler M. H., Solimena M., Dirkx R. Jr, Hayday A., De Camilli P. Identification of a dominant epitope of glutamic acid decarboxylase (GAD-65) recognized by autoantibodies in stiff-man syndrome. J Exp Med: 1993; 178 6 2097 2106
21. Ali F., Rowley M., Jayakrishnan B., Teuber S., Gershwin M. E., Mackay I. R. Stiff-person syndrome (SPS) and anti-GAD-related CNS degenerations: protean additions to the autoimmune central neuropathies. J Autoimmun: 2011; 37 2 79 87
22. Walikonis J. E., Lennon V. A. Radioimmunoassay for glutamic acid decarboxylase (GAD65) autoantibodies as a diagnostic aid for stiff-man syndrome and a correlate of susceptibility to type 1 diabetes mellitus. Mayo Clin Proc: 1998; 73 12 1161 1166
23. Christgau S., Aanstoot H. J., Schierbeck H., et al. Membrane anchoring of the autoantigen GAD65 to microvesicles in pancreatic beta-cells by palmitoylation in the NH2-terminal domain. J Cell Biol: 1992; 118 2 309 320
24. Reetz A., Solimena M., Matteoli M., Folli F., Takei K., De Camilli P. GABA and pancreatic beta-cells: colocalization of glutamic acid decarboxylase (GAD) and GABA with synaptic-like microvesicles suggests their role in GABA storage and secretion. EMBO J: 1991; 10 5 1275 1284
25. Hutchinson M., Waters P., McHugh J., et al. Progressive encephalomyelitis, rigidity, and myoclonus: a novel glycine receptor antibody. Neurology: 2008; 71 16 1291 1292
26. Mas N., Saiz A., Leite M. I., et al. Antiglycine-receptor encephalomyelitis with rigidity. J Neurol Neurosurg Psychiatry: 2011; 82 12 1399 1401
27. Raju R., Rakocevic G., Chen Z., et al. Autoimmunity to GABAA-receptor-associated protein in stiff-person syndrome. Brain: 2006; 129 Pt 12 3270 3276
28. Ishida K., Mitoma H., Song S. Y., et al. Selective suppression of cerebellar GABAergic transmission by an autoantibody to glutamic acid decarboxylase. Ann Neurol: 1999; 46 2 263 267
29. Mitoma H., Song S. Y., Ishida K., Yamakuni T., Kobayashi T., Mizusawa H. Presynaptic impairment of cerebellar inhibitory synapses by an autoantibody to glutamate decarboxylase. J Neurol Sci: 2000; 175 1 40 44
30. Manto M. U., Laute M. A., Aguera M., Rogemond V., Pandolfo M., Honnorat J. Effects of anti-glutamic acid decarboxylase antibodies associated with neurological diseases. Ann Neurol: 2007; 61 6 544 551
31. Rakocevic G., Raju R., Semino-Mora C., Dalakas M. C. Stiff person syndrome with cerebellar disease and high-titer anti-GAD antibodies. Neurology: 2006; 67 6 1068 1070
32. Dalakas M. C. Advances in the pathogenesis and treatment of patients with stiff person syndrome. Curr Neurol Neurosci Rep: 2008; 8 1 48 55
33. Murinson B. B., Guarnaccia J. B. Stiff-person syndrome with amphiphysin antibodies: distinctive features of a rare disease. Neurology: 2008; 71 24 1955 1958
34. Holmoy T., Skorstad G., Roste L. S., Scheie D., Alvik K. Stiff person syndrome associated with lower motor neuron disease and infiltration of cytotoxic T cells in the spinal cord. Clin Neurol Neurosurg: 2009; 111 8 708 712
35. Witherick J., Highley J. R., Hadjivassiliou M. Pathological findings in a case of stiff person syndrome with anti-GAD antibodies. Mov Disord: 2011; 26 11 2138 2139
36. Ishida K., Mitoma H., Wada Y., et al. Selective loss of Purkinje cells in a patient with anti-glutamic acid decarboxylase antibody-associated cerebellar ataxia. J Neurol Neurosurg Psychiatry: 2007; 78 2 190 192
37. Dalakas M. C. The role of IVIg in the treatment of patients with stiff person syndrome and other neurological diseases associated with anti-GAD antibodies. J Neurol: 2005; 252 01 I19 I25
38. Bonnan M., Cabre P., Olindo S., Signate A., Saint-Vil M., Smadja D. Steroid treatment in four cases of anti-GAD cerebellar ataxia [in French]. Rev Neurol (Paris): 2008; 164 5 427 433
39. Lauria G., Pareyson D., Pitzolu M. G., Bazzigaluppi E. Excellent response to steroid treatment in anti-GAD cerebellar ataxia. Lancet Neurol: 2003; 2 10 634 635
40. Nanri K., Okita M., Takeguchi M., et al. Intravenous immunoglobulin therapy for autoantibody-positive cerebellar ataxia. Intern Med: 2009; 48 10 783 790
41. Vulliemoz S., Vanini G., Truffert A., Chizzolini C., Seeck M. Epilepsy and cerebellar ataxia associated with anti-glutamic acid decarboxylase antibodies. J Neurol Neurosurg Psychiatry: 2007; 78 2 187 189